Today on in-pharmatechnologist.com   Safety warning delays Novartis diabetes drug Satraplatin ruling in GPC Biotech favour Pharmaceutical patent round-up Cash injection for anthrax jab Contract manufacturing news in brief

Related Industry News   Apitope vaccine stops MS in its tracks Varian snaps up Analogix in a flash Icon improves its position, Kendle slips again Pretender to Avastin throne poised to enter clinical trails

Breaking News on Pharmaceutical Technology - Europe
Daily  Tuesday 06 November 2007		Forward to a colleague

	Sponsored Link New filler/binder for ODT production Latest research shows that PALATINIT's galenIQ™ 720 and 721 are perfect alternatives for ODT formulations due to a fast disintegration time even without additional super-disintegrants... Click Here Access Full Stories Safety warning delays Novartis diabetes drug Swiss firm Novartis today announced that it has contacted regulators regarding the safety of the 100mg dose of its recently approved Type II diabetes drug, Galvus (vildagliptin)... Read Satraplatin ruling in GPC Biotech favour GPC Biotech has found a ray of light in the satraplatin quagmire following an arbitration ruling in favour of the Germany-based biopharmaceutical company... Read Pharmaceutical patent round-up In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations... Read Cash injection for anthrax jab US firms Medarex and PharmAthene today announced that they are to receive additional funding from the US Government to support the ongoing development of their anthrax therapeutic, Valortim... Read Contract manufacturing news in brief Bioserv Corporation, Mikart, Laureate Pharma, Cenexi and Lonza have all recently announced new contract manufacturing news... Read
	All News Headlines for: November | October | September
	Sponsored Link Oncological API Specialist ScinoPharm, specialized in manufacturing cGMP grade oncological APIs, offers fully integrated services to develop and manufacture final APIs capabilities including process research and development, analytical development and regulatory submission... Click Here
	Advertisement Related Industry News Apitope vaccine stops MS in its tracks UK biopharmaceutical firm Apitope has developed a vaccine that could halt multiple sclerosis in its relentless march to destroy nerve cells... Read Varian snaps up Analogix in a flash Scientific instrument and vacuum technology supplier Varian has acquired the assets of US flash chromatography expert Analogix for $11m (€7.6m) cash plus the assumption of its net debt... Read Icon improves its position, Kendle slips again Icon has improved its financial position significantly during its third quarter, while its smaller US rival Kendle saw its profit slip again, weighed down by charges from a 2006 acquisition... Read Pretender to Avastin throne poised to enter clinical trails BioInvent and ThromboGenics' new anticancer antibody is poised to enter clinical trials and could prove a serious rival to VEGF-blocking drugs, due to fewer side-effects and less drug resistance... Read Weekly Comment Big pharma lends a helping hand Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis. Read Product Presentation Supremely Flexible: Spray Drying from Niro The new PSD-1 pharmaceutical spray dryer from Niro allows you to perform exacting R&D as well as production of IMP's and small-scale manufacturing with one and the same unit. Drying with the PHARMASD series of spray dryers gives you optimum control of product properties... Click Here Previous Headlines GSK, Fabre-Kramer lose out on antidepressant GlaxoSmithKline (GSK) and Fabre-Kramer Pharmaceuticals (FKP) were dealt a blow last week as their potential first in class, once-daily antidepressant treatment received another thumbs down from US regulators... Read Flutiform safety results a 'significant milestone' UK-based SkyePharma has been given a boost in regards to its asthma treatment following the release of positive Phase III results... Read FDA failure on foreign inspections frightening A US government audit has confirmed the Food and Drug Administration's (FDA's) continual lack of inspection of foreign drug manufacturing plants... Read Japan's Tamiflu supply halved Japan will only be receiving 50 per cent of its usual supply of the blockbuster flu drug Tamiflu (oseltamivir) this year, thanks to significantly reduced demand following reports of suicidal behaviour in adolescents... Read Neural stem cell drug delivery is encapsulating Inherited genetic disorders could be treated with a new stem cell-based drug delivery therapy through the use of microcapsules... Read Product Information - brochures, Web centers The Safe'n'Sound Passive Safety Device for Prefilled Syringes - Product Presentation A Review of Dissolution tests with the Flow Through Method - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Cleanroom, safety equipment, supplies Contract services (outsourcing) Drug delivery systems Ingredients, excipients and raw materials IT solutions Lab equipment & consumables Packaging machinery & supplies Processing (automation, control, separation...) QA/QC & validation Tabletting, coating & ancillary equipment

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com